vs
Amarin Corp plc（AMRN）与Ponce Financial Group, Inc.（PDLB）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是Ponce Financial Group, Inc.的1.4倍（$45.1M vs $31.4M），Ponce Financial Group, Inc.净利率更高（36.3% vs -23.3%，领先59.6%），Ponce Financial Group, Inc.同比增速更快（37.6% vs 7.0%），过去两年Ponce Financial Group, Inc.的营收复合增速更高（23.7% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
庞塞金融集团是总部位于美国的金融控股公司，核心子公司为庞塞银行，主要服务纽约大都会区的多元文化、移民及中低收入社区，提供存款账户、按揭贷款、小微企业融资、个人信贷等零售及商业银行服务。
AMRN vs PDLB — 直观对比
营收规模更大
AMRN
是对方的1.4倍
$31.4M
营收增速更快
PDLB
高出30.6%
7.0%
净利率更高
PDLB
高出59.6%
-23.3%
两年增速更快
PDLB
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $31.4M |
| 净利润 | $-10.5M | $10.1M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 43.6% |
| 净利率 | -23.3% | 36.3% |
| 营收同比 | 7.0% | 37.6% |
| 净利润同比 | 33.0% | 245.6% |
| 每股收益（稀释后） | — | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNPDLB
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $31.4M | ||
| Q3 25 | $49.7M | $26.7M | ||
| Q2 25 | $72.7M | $26.5M | ||
| Q1 25 | $42.0M | $24.6M | ||
| Q4 24 | $62.3M | $22.8M | ||
| Q3 24 | $42.3M | $20.2M | ||
| Q2 24 | $67.5M | $20.2M |
净利润AMRNPDLB
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $10.1M | ||
| Q3 25 | $-7.7M | $6.5M | ||
| Q2 25 | $-14.1M | $6.1M | ||
| Q1 25 | $-15.7M | $6.0M | ||
| Q4 24 | $-48.6M | $2.9M | ||
| Q3 24 | $-25.1M | $2.4M | ||
| Q2 24 | $1.5M | $3.2M |
毛利率AMRNPDLB
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNPDLB
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 43.6% | ||
| Q3 25 | -22.4% | 32.8% | ||
| Q2 25 | -22.0% | 30.2% | ||
| Q1 25 | -39.9% | 32.5% | ||
| Q4 24 | -84.3% | 19.6% | ||
| Q3 24 | -59.5% | 15.2% | ||
| Q2 24 | -0.8% | 21.8% |
净利率AMRNPDLB
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 36.3% | ||
| Q3 25 | -15.6% | 24.3% | ||
| Q2 25 | -19.4% | 23.0% | ||
| Q1 25 | -37.4% | 24.2% | ||
| Q4 24 | -78.0% | 14.1% | ||
| Q3 24 | -59.4% | 12.1% | ||
| Q2 24 | 2.3% | 15.8% |
每股收益（稀释后）AMRNPDLB
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.43 | ||
| Q3 25 | $-0.02 | $0.27 | ||
| Q2 25 | $-0.03 | $0.25 | ||
| Q1 25 | $-0.04 | $0.25 | ||
| Q4 24 | $-0.12 | $0.11 | ||
| Q3 24 | $-0.06 | $0.10 | ||
| Q2 24 | $0.00 | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $126.2M |
| 总债务越低越好 | — | $596.1M |
| 股东权益账面价值 | — | $541.5M |
| 总资产 | $645.8M | $3.2B |
| 负债/权益比越低杠杆越低 | — | 1.10× |
8季度趋势，按日历期对齐
现金及短期投资AMRNPDLB
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $126.2M | ||
| Q3 25 | $286.6M | $146.6M | ||
| Q2 25 | $298.7M | $126.6M | ||
| Q1 25 | $281.8M | $129.9M | ||
| Q4 24 | $294.2M | $139.8M | ||
| Q3 24 | $305.7M | $155.8M | ||
| Q2 24 | $306.7M | $103.2M |
总债务AMRNPDLB
| Q1 26 | — | — | ||
| Q4 25 | — | $596.1M | ||
| Q3 25 | — | $521.1M | ||
| Q2 25 | — | $536.1M | ||
| Q1 25 | — | $521.1M | ||
| Q4 24 | — | $596.1M | ||
| Q3 24 | — | $580.4M | ||
| Q2 24 | — | $680.4M |
股东权益AMRNPDLB
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $541.5M | ||
| Q3 25 | $458.9M | $529.8M | ||
| Q2 25 | $464.9M | $521.1M | ||
| Q1 25 | $473.7M | $513.9M | ||
| Q4 24 | $486.2M | $505.5M | ||
| Q3 24 | $531.4M | $504.6M | ||
| Q2 24 | $551.9M | $497.7M |
总资产AMRNPDLB
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $3.2B | ||
| Q3 25 | $659.8M | $3.2B | ||
| Q2 25 | $670.1M | $3.2B | ||
| Q1 25 | $655.7M | $3.1B | ||
| Q4 24 | $685.3M | $3.0B | ||
| Q3 24 | $750.6M | $3.0B | ||
| Q2 24 | $799.9M | $2.8B |
负债/权益比AMRNPDLB
| Q1 26 | — | — | ||
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.37× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $55.6M |
| 自由现金流经营现金流 - 资本支出 | — | $54.6M |
| 自由现金流率自由现金流/营收 | — | 173.9% |
| 资本支出强度资本支出/营收 | — | 3.1% |
| 现金转化率经营现金流/净利润 | — | 5.48× |
| 过去12个月自由现金流最近4个季度 | — | $74.3M |
8季度趋势，按日历期对齐
经营现金流AMRNPDLB
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $55.6M | ||
| Q3 25 | $-12.7M | $1.4M | ||
| Q2 25 | $16.6M | $6.2M | ||
| Q1 25 | $-12.5M | $13.1M | ||
| Q4 24 | $-13.3M | $7.2M | ||
| Q3 24 | $-2.4M | $-14.6M | ||
| Q2 24 | $-2.7M | $-2.6M |
自由现金流AMRNPDLB
| Q1 26 | — | — | ||
| Q4 25 | — | $54.6M | ||
| Q3 25 | — | $786.0K | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $12.9M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $-15.0M | ||
| Q2 24 | — | $-2.6M |
自由现金流率AMRNPDLB
| Q1 26 | — | — | ||
| Q4 25 | — | 173.9% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 22.4% | ||
| Q1 25 | — | 52.6% | ||
| Q4 24 | — | 19.7% | ||
| Q3 24 | — | -74.1% | ||
| Q2 24 | — | -13.0% |
资本支出强度AMRNPDLB
| Q1 26 | — | — | ||
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 11.9% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 0.3% |
现金转化率AMRNPDLB
| Q1 26 | — | — | ||
| Q4 25 | — | 5.48× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 2.46× | ||
| Q3 24 | — | -5.99× | ||
| Q2 24 | -1.81× | -0.80× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
PDLB
暂无分部数据
